Abstract
Although cervical cancer is decreasing in the United States, because screening is widely used, it is increasing in developing countries (approximately 270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (e.g., surgery, concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I and II) and in 60% with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of HPV, and is therefore expected to prevent specific HPV cancer in women.9,69
Original language | English (US) |
---|---|
Pages (from-to) | 14-36 |
Number of pages | 23 |
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 6 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2008 |
Keywords
- Cervical cancer
- Chemotherapy
- Human papillomavirus
- Hysterectomy
- NCCN clinical practice guidelines
- Radiation therapy
ASJC Scopus subject areas
- Oncology